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S-Phenylcysteine in Albumin
as a Benzene Biomarker
William E. Bechtold and Michael R. Strunk
Inhalation Toxicology Research Institute, Albuquerque, New Mexico
Biological markers of internal dose are useful for improving the extrapolation of health effects
from exposures to high levels of toxic air pollutants in animals to low, ambient exposures in
humans. Previous results from our laboratory have shown that benzene is metabolized by
humans to form the adduct S-phenylcysteine (SPC). Levels of SPC measured in humans occupa-
tionally exposed to benzene were increased linearly relative to exposure concentrations ranging
from 0 to 23.1 ppm for 8 hr/day, 5 days/week. However, the method of measurement used was
laborious, prone to imprecision and interferences, and insufficiently sensitive for the low-dose
exposures anticipated in the United States (100 ppb>). An improved chemical method was nec-
essary before SPC adducts in albumin could be used as a benzene biomarker. A simple, sensitive
method to measure SPC adducts is being developed and is based on the cleavage of the cysteine
sulfhydryl from blood proteins treated with Raney nickel (RN) in deuterium oxide. The product of
the reaction with SPC is monodeuterobenzene. SPC treated with RN released monodeuteroben-
zene in a concentration-dependent fashion. SPC was measured by RN treatment of globin from
rats repeatedly exposed by inhalation to 600 ppm benzene. SPC levels measured using the RN
approach were 690 ± 390 pmol SPC/mg Hb (mean ± % difference, n =2), as opposed to 290 ± 45
pmol SPC/mg Hb (mean ± SEM, n =3) as measured by our previous method. This method may
facilitate the cost-effective, routine analysis of SPC in large populations of people exposed to
ambient levels of benzene. Environ Health Perspect 104(Suppl 6):1147-1149 (1996)
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Introduction
Risk assessment for toxic air pollutants is
often based on the extrapolation ofhealth
effects from high levels of exposure in
animals to ambient exposures in human.
The underlying biological and chemical
processes that constitute exposure and con-
sequent effects may not be understood,
which weakens the validity ofthese extrap-
olations. One means of more accurately
defining these processes is by the use of
biological markers of internal dose. Our
laboratory has been developing biological
markers to the human carcinogen benzene;
results have shown that benzene is, in part,
metabolized by humans to an intermediate
that binds to cysteine groups in albumin to
form the adduct S-phenylcysteine (SPC).
We have measured the formation of SPC
in albumin in workers after benzene
exposure (1) and levels of SPC in humans
occupationally exposed to average concen-
trations of0, 4.4, 8.4, and 23.1 ppm ben-
zene 8 hr/day, 5 days/week. SPC increased
linearly in the exposed group, giving a
statistically significant slope (p< 0.001) of
0.044 ± 0.008 pmol/(mg albumin x ppm),
with an intercept of0.135 ±0.095 pmol/mg
albumin. Although SPC in albumin may
prove useful as a biomarker of benzene
exposure, considerable sensitivity would
be required to measure SPC in the albu-
min of people routinely exposed to ben-
zene in environmental settings. Measuring
SPC routinely by our current method
would be difficult because it is laborious
and prone to imprecision and interferences.
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An alternate approach to measure SPC was
therefore sought.
This article describes a new method
based on the cleavage of the cysteine
sulfhydryl from the albumin by treatment
with Raney nickel (RN) in D20. For SPC
the product ofthe reaction was the release
ofmonodeuterobenzene (MDB) (Figure 1).
The released MDB was purged from the
RN solution with helium and trapped by
passing the vapor through a cartridge con-
taining the adsorbent substance Carbotrap
(Alltech, Deerfield, IL). The trapped
benzene was then desorbed from the car-
tridge using a Tekmar thermal desorption
apparatus (Tekmar, Cincinnati, OH). The
benzene released from the desorption appa-
ratus was analyzed by gas chromatograph-
mass spectrometer (GC-MS). Incomplete
reaction of the SPC with RN and inef-
ficiencies in the purging and desorption
process were corrected by adding a known
amount of['3C61SPC standard to the reac-
tion mixture. Initial results are described
toward the development of the assay that
establishes its efficacy.
Materials and Methods
Reagents
The SPC and [i3C6]SPC have been syn-
thesized (2). The deuterium oxide (99%<)
was acquired from Aldrich (Aldrich,
Milwaukee, WI) and an aqueous suspen-
sion of RN. To purge as much benzene
from the suspension as possible, the water
was removed from the RN on a vacuum
line and displaced with D20 prior to use.
The RN was kept tightly sealed until used.
Carbotrap was acquired from Alltech. All
other reagents were acquired from Aldrich
and were of>99% purity.
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Figure 1. Reaction of S-phenylcysteine with Raney
nickel in D20 to produce monodeuterobenzene.
Environmental Health Perspectives a Vol 104, Supplement 6 * December 1996
"Plig-mp
1 147BECHTOLD AND STRUNK
Globin Isolation andHydrolysis
Globin was isolated from the red blood
cells as previously described (1). The isola-
tion process frees the heme group from the
globin protein. Globin was hydrolyzed in
flame-sealed vials by adding 10 ml of6 N
HCI to 500 mg of protein. After purging
with dry nitrogen, the vials were sealed and
incubated at 1100 C for 24 hr. The vials
were opened, and the hydrolysates brought
to dryness with a stream of dry nitrogen.
Aliquots of the [13C6]SPC internal stan-
dard solution (about 50 pmol of internal
standard) were added and the samples
reconstituted in D20.
RaneyNickel Reduction ofGlobin and
Analysis byPurg andTrap GC-MS
The protein hydrolysate was treated with
RN catalyst for cleavage ofMDB. To a 50
ml crimp-top vial we added 300 mg RN
catalyst and 50 mg protein in 5 ml D20
made basic with NaOD. The contents
were allowed to react at 60°C for 15 min.
MDB was purged at 60°C for 15 min with
a helium flow of 30 ml/min and trapped
from the reaction vial. The helium was
introduced using a 5-inch 18-gauge nee-
dle and exited from the vial through a
deactivated silica column. The column in
turn was introduced into the Carbotrap
within the Tekmar. The trap was held at
room temperature.
A Tekmar 5010 thermal desorption
apparatus (Tekmar) with a Cryo-2 capil-
lary interface was used to analyze the
Carbotrap trap. The trap was desorbed at
400C for 10 min into the internal trap of
the Tekmar. The cryogenically focused
desorbate was heated and transferred to the
capillary interface, which was ballistically
heated for injection onto the GC-MS.
Analysis included a J&W DB1701
column held isothermally at 500C for 1.2
min and 10°C/min to 100°C. A Hewlett
Packard 5890/5970B GC-MSD (Hewlett-
Packard, Wilmington, DE) was operated
using selected monitoring of ions 85, 79,
78, and 50. These ions represent the
internal standard, MDB, benzene back-
ground, and a confirmation ion, respec-
tively. Limits of detection for the
instrument were determined by injecting
100-pl aliquots of benzene vapor through
the splittless injector.
Benzene Exposure
Globin was acquired from F344/N rats
repeatedly exposed to 600 ppm benzene
over 2 weeks for 6 hr per day. These
studies have been described (2).
Results
To characterize the recovery of any ben-
zene cleaved by the RN process, a 100-pg
sample of benzene was spiked onto the
Carbotrap. The benzene was measured by
thermal desorption GC-MS, which gave a
recovery of 103% relative to benzene
injected directly onto the GC-MS through
the splittless interface. Direct injections
onto the GC-MS suggested an instrument
limit ofdetection ofabout 20 pg (signal to
noise of 3:1). Graded amounts of SPC
standard were treated with RN in D20,
followed by purge-and-trap GC-MS
(Figure 2). Response was linear over the
region of interest (r2 > 0.99), although a
nonzero intercept was encountered for the
blank and the fitted curve.
SPC was measured by RN treatment of
globin from rats repeatedly exposed by
inhalation to 600 ppm benzene. A chro-
matogram for the released MDB demon-
strates the expected coelution with the
internal standard (Figure 3). SPC levels
measured using the RN approach were
690 ± 390 pmol SPC/mg Hb (mean ± %
difference, n = 2), as opposed to 290 45
pmol SPC/mg Hb as measured by our
previous method (mean ± SEM, n= 3).
Because ofhigh backgrounds in blanks,
lower levels of MDB released from SPC
were not measured.
Discussion
The RN method has several key advantages
relative to our prior approach. First, the
purge-and-trap process is expected to liber-
ate most, if not all, the cleaved benzene
from the solution. Therefore, most ofthe
analyte is delivered to the MS, as opposed
to only a fraction of that delivered by the
previous method. This should increase the
sensitivity of the method considerably.
Sensitivity is further enhanced because
most MSs, including ours, are more sensi-
tive in analyzing low versus high mass
compounds when using electron impact
ionization. The weights of the released
MDB and the derivatized SPC are 79 and
449, respectively. In addition, only volatile
materials are transferred to the GC, thus
reducing the amount of nonvolatile
residues and decreasing nonspecific inter-
ferences. Finally, this procedure may be
automated using purge-and-trap autosam-
plers, which would make the method less
labor intensive and more cost effective.
Ultratrace levels ofbenzene in aqueous
samples are difficult to measure routinely
because benzene is pervasive in the labora-
tory, and blanks for the reaction are often
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Figure 2. S-Phenylcysteine analyzed by cleavage in
Raney nickel and purge-and-trap GC-MS analysis.
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Figure 3. Chromatogram of monodeuterobenzene
released from rat globin by Raney nickel.
high and hard to reduce. To partially over-
come this problem, we conducted the reac-
tion in deuterium oxide and anticipated
MDB as the product of this reaction.
Background benzene still contributed to
blanks because of the identical molecular
weights for MDB and [13CI]benzene at
unit mass resolution. The [13Cl]benzene
contributed signal because 6% of all ben-
zene will contain a 13C atom, which exists
in 1% natural abundance. Therefore, a
factor of 17 (100/6) reduction in back-
ground resulted. Nonetheless, the appara-
tus (Tekmar 5000) used for these studies
was not specifically designed for purge-
and-trap analysis; it suffered from exces-
sive background and memory effects and
limited our ability to measure lower levels
ofSPC.
Ofconcern for any biological marker is
its specificity for the toxicant of interest.
SPC levels in the albumin ofcontrol indi-
viduals are not expected to be high, based
on studies of the urinary excretion of the
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benzene metabolite phenylmercapturic
acid. Both phenylmercapturic acid and SPC
should be formed by the binding ofben-
zene oxide to cysteine groups. Phenylmer-
capturic acid levels have been measured in
the urine ofworkers occupationally exposed
to benzene and were found to be low in
unexposed workers (3). Levels increased
gradually in workers exposed to benzene
levels up to 1 ppm.
While our initial results appear promis-
ing, the method can be further refined to
measure these lower levels ofSPC. Ofgreat-
est concern is a further reduction in the
background ofbenzene. Use ofa commer-
cially available purge-and-trap apparatus
will solve this problem. Method detection
limits for benzene have been reported as
low as 0.006 ppb [30 pg benzene in 5 ml
water; (4)]. The purge-and-trap apparatus
has recently been acquired in our labora-
tory; experiments using this instrument
suggest these limits will be attainable.
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